share_log

华纳药厂(688799.SH)拟通过基金探索中国、东南亚等市场医疗大健康领域投资机会

Warner Pharmaceuticals (688799.SH) plans to explore investment opportunities in the medical and health sector in markets such as China and Southeast Asia through funds

Zhitong Finance ·  May 23 05:36

Warner Pharmaceuticals (688799.SH) announced that the company plans to invest no more than RMB 40 million to pledge Hainan Heyi...

Zhitong Finance App News, Warner Pharmaceuticals (688799.SH) announced that the company plans to invest no more than RMB 40 million to pledge 17.9767% of the investment amount of Hainan Heyi Vision Private Equity Investment Fund Partnership (Limited Partnership) (“Heyi Vision”). According to reports, the fund is positioned as an early growth stage venture capital fund in the medical and health sector. It focuses on innovation and value investment in the fields of biotechnology, innovative drugs, medical services, and medical devices, and aims to invest in startups in the medical and health sector in markets such as China and Southeast Asia.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment